Doxorubicin Injection 50 mg 1 Vial (imp) works by slowing or stopping the growth of cancer cells.
Side effects
Major & minor side effects for Doxorubicin Injection 50 mg 1 Vial (imp)
Decrease in white blood cells and platelets severe
Pain at the injection site severe
Fever with chills severe
Skin rash severe
Hair loss
Nausea and Vomiting
Mouth ulcers
Loss of appetite
Diarrhea
Weight loss
Uses of Doxorubicin Injection 50 mg 1 Vial (imp)
What is it prescribed for?
Ovarian Cancer
Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection is used in the treatment of the cancer that affects the female reproductive system.
Breast Cancer
Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection is used in the treatment of breast cancer.
Hodgkin’s Disease
Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection is used in the treatment of cancer that affects the immune system.
Multiple Myeloma
Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection is used in the treatment of cancer that affects the plasma cells (a type of blood cell) inside the bone marrow.
Concerns
Frequently asked questions
Onset of action
The peak levels of this medicine can be reached immediately after intravenous injection.
Duration of Effect
The effect of this medicine lasts for an average duration of 1 to 2 days
Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Is it habit forming?
No habit forming tendency has been reported.
Usage in pregnancy?
This medicine is not recommended for use in pregnant women.
Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women.
When not to use?
Allergy
Not recommended in patients with known history of allergy to Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection.
Warnings
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women.
Breast-feeding
This medicine is not recommended for use in breastfeeding women.
General Warnings
Effect on heart
Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection may increase the risk of toxic effects on the heart and could lead to acute left ventricular failure. Patients with history of heart disease need close monitoring while receiving this medicine.
Infections
The chances of infections occurring are more in patients receiving this medicine. Hold the chemotherapy and start with broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary in such cases.
Blood cell count
Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection is known to lower the white blood cell count (neutrophils) in patients with risk factors such as pre-existing diseases or medicines. Close monitoring of blood cell count is necessary. Do not start the treatment if the blood cell count is low.
Secondary oral neoplasms
Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection is known to increase the risk of secondary cancers, most frequently in the mouth. Close monitoring of symptoms like mouth ulcers, bleeding is necessary. The treatment should be discontinued if secondary cancer develops.
Dosage
Missed Dose
It is advised that you do not miss any dose. If you miss any dose, you should contact your doctor immediately.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
Interactions
Interaction with Medicines
Clozapine severe
Diltiazem moderate
Live attenuated vaccines and related products severe
Dexamethasone moderate
General Instructions
Take Doxorubicin Injection 50 mg 1 Vial (imp) 50 mg Injection under the supervision of a qualified healthcare professional. It should be given with other chemotherapy agents in multiple cycles. It is important to receive every scheduled dose for better cancer suppression. The blood cell counts should be monitored before initiating the treatment. Close monitoring of heart function is necessary while receiving this medicine.
Other details
Can be taken with or without food, as advised by your doctor
To be taken as instructed by doctor
Does not cause sleepiness
References
webmd.com –
Doxorubicin [Internet].
Available from: https://www.webmd.com/drugs/2/drug-7750/doxorubicin-intravenous/details
[cited 7/7/2020].
Reviews
There are no reviews yet.